Medicines boss: Costly new cancer drugs not working
Just one in 20 new cancer drugs assessed for the Irish market since the beginning of 2016 were considered value for money, according to a new assessment by the NCPE
Most new cancer drugs are not worth the money being sought by pharmaceutical companies, the head of the state’s medicines watchdog has said in a stark assessment.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
